Global Retinal Biologics Market Growth (Status and Outlook) 2019-2024
Table of Contents
2019-2024 Global Retinal Biologics Market Report (Status and Outlook)
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Retinal Biologics Market Size 2014-2024
- 2.1.2 Retinal Biologics Market Size CAGR by Region
- 2.2 Retinal Biologics Segment by Type
- 2.2.1 Macular Degeneration
- 2.2.2 Diabetic Retinopathy
- 2.2.3 Diabetic Macular Edema
- 2.2.4 Uveitis
- 2.2.5 Others
- 2.3 Retinal Biologics Market Size by Type
- 2.3.1 Global Retinal Biologics Market Size Market Share by Type (2014-2019)
- 2.3.2 Global Retinal Biologics Market Size Growth Rate by Type (2014-2019)
- 2.4 Retinal Biologics Segment by Application
- 2.4.1 Hospitals
- 2.4.2 Clinics
- 2.4.3 Others
- 2.5 Retinal Biologics Market Size by Application
- 2.5.1 Global Retinal Biologics Market Size Market Share by Application (2014-2019)
- 2.5.2 Global Retinal Biologics Market Size Growth Rate by Application (2014-2019)
3 Global Retinal Biologics by Players
- 3.1 Global Retinal Biologics Market Size Market Share by Players
- 3.1.1 Global Retinal Biologics Market Size by Players (2017-2019)
- 3.1.2 Global Retinal Biologics Market Size Market Share by Players (2017-2019)
- 3.2 Global Retinal Biologics Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Retinal Biologics by Regions
- 4.1 Retinal Biologics Market Size by Regions
- 4.2 Americas Retinal Biologics Market Size Growth
- 4.3 APAC Retinal Biologics Market Size Growth
- 4.4 Europe Retinal Biologics Market Size Growth
- 4.5 Middle East & Africa Retinal Biologics Market Size Growth
5 Americas
- 5.1 Americas Retinal Biologics Market Size by Countries
- 5.2 Americas Retinal Biologics Market Size by Type
- 5.3 Americas Retinal Biologics Market Size by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Retinal Biologics Market Size by Countries
- 6.2 APAC Retinal Biologics Market Size by Type
- 6.3 APAC Retinal Biologics Market Size by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Retinal Biologics by Countries
- 7.2 Europe Retinal Biologics Market Size by Type
- 7.3 Europe Retinal Biologics Market Size by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Retinal Biologics by Countries
- 8.2 Middle East & Africa Retinal Biologics Market Size by Type
- 8.3 Middle East & Africa Retinal Biologics Market Size by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Global Retinal Biologics Market Forecast
- 10.1 Global Retinal Biologics Market Size Forecast (2019-2024)
- 10.2 Global Retinal Biologics Forecast by Regions
- 10.2.1 Global Retinal Biologics Forecast by Regions (2019-2024)
- 10.2.2 Americas Market Forecast
- 10.2.3 APAC Market Forecast
- 10.2.4 Europe Market Forecast
- 10.2.5 Middle East & Africa Market Forecast
- 10.3 Americas Forecast by Countries
- 10.3.1 United States Market Forecast
- 10.3.2 Canada Market Forecast
- 10.3.3 Mexico Market Forecast
- 10.3.4 Brazil Market Forecast
- 10.4 APAC Forecast by Countries
- 10.4.1 China Market Forecast
- 10.4.2 Japan Market Forecast
- 10.4.3 Korea Market Forecast
- 10.4.4 Southeast Asia Market Forecast
- 10.4.5 India Market Forecast
- 10.4.6 Australia Market Forecast
- 10.5 Europe Forecast by Countries
- 10.5.1 Germany Market Forecast
- 10.5.2 France Market Forecast
- 10.5.3 UK Market Forecast
- 10.5.4 Italy Market Forecast
- 10.5.5 Russia Market Forecast
- 10.5.6 Spain Market Forecast
- 10.6 Middle East & Africa Forecast by Countries
- 10.6.1 Egypt Market Forecast
- 10.6.2 South Africa Market Forecast
- 10.6.3 Israel Market Forecast
- 10.6.4 Turkey Market Forecast
- 10.6.5 GCC Countries Market Forecast
- 10.7 Global Retinal Biologics Forecast by Type
- 10.8 Global Retinal Biologics Forecast by Application
11 Key Players Analysis
- 11.1 Spark Therapeutics, Inc
- 11.1.1 Company Details
- 11.1.2 Retinal Biologics Product Offered
- 11.1.3 Spark Therapeutics, Inc Retinal Biologics Revenue, Gross Margin and Market Share (2017-2019)
- 11.1.4 Main Business Overview
- 11.1.5 Spark Therapeutics, Inc News
- 11.2 F. Hoffmann-La Roche Ltd
- 11.2.1 Company Details
- 11.2.2 Retinal Biologics Product Offered
- 11.2.3 F. Hoffmann-La Roche Ltd Retinal Biologics Revenue, Gross Margin and Market Share (2017-2019)
- 11.2.4 Main Business Overview
- 11.2.5 F. Hoffmann-La Roche Ltd News
- 11.3 Regeneron Pharmaceuticals, Inc
- 11.3.1 Company Details
- 11.3.2 Retinal Biologics Product Offered
- 11.3.3 Regeneron Pharmaceuticals, Inc Retinal Biologics Revenue, Gross Margin and Market Share (2017-2019)
- 11.3.4 Main Business Overview
- 11.3.5 Regeneron Pharmaceuticals, Inc News
- 11.4 AbbVie Inc
- 11.4.1 Company Details
- 11.4.2 Retinal Biologics Product Offered
- 11.4.3 AbbVie Inc Retinal Biologics Revenue, Gross Margin and Market Share (2017-2019)
- 11.4.4 Main Business Overview
- 11.4.5 AbbVie Inc News
- 11.5 Johnson & Johnson Services, Inc
- 11.5.1 Company Details
- 11.5.2 Retinal Biologics Product Offered
- 11.5.3 Johnson & Johnson Services, Inc Retinal Biologics Revenue, Gross Margin and Market Share (2017-2019)
- 11.5.4 Main Business Overview
- 11.5.5 Johnson & Johnson Services, Inc News
- 11.6 Amgen Inc
- 11.6.1 Company Details
- 11.6.2 Retinal Biologics Product Offered
- 11.6.3 Amgen Inc Retinal Biologics Revenue, Gross Margin and Market Share (2017-2019)
- 11.6.4 Main Business Overview
- 11.6.5 Amgen Inc News
...
12 Research Findings and Conclusion
Many retinal biologics have been approved by the Food and Drug Administration (FDA), the European Medicine Agency (EMA) and the China Food and Drug Administration (CFDA) for the treatment of retinal diseases. Advancements in technologies and new mechanism of action for different biologics to treat retinal diseases are anticipated to boost the retinal biologics market.
According to this study, over the next five years the Retinal Biologics market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Retinal Biologics business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Retinal Biologics market by product type, application, key companies and key regions.
This study considers the Retinal Biologics value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Macular Degeneration
Diabetic Retinopathy
Uveitis
Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Hospitals
Clinics
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Spark Therapeutics, Inc
F. Hoffmann-La Roche Ltd
Regeneron Pharmaceuticals, Inc
AbbVie Inc
Johnson & Johnson Services, Inc
Amgen Inc
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Retinal Biologics market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Retinal Biologics market by identifying its various subsegments.
Focuses on the key global Retinal Biologics players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Retinal Biologics with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Retinal Biologics submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.